Data Standards/CDISC
Biometrics Expertise for Clinical Trials and Regulatory Submissions
Every clinical development decision depends on data you can trust. Our biometrics experts combine deep scientific expertise with InStat™ technology to get you there faster.
Biometrics Expertise for Clinical Trials and Regulatory Submissions
Getting a therapy to the patients who need it takes trial data that is designed, collected, and analyzed correctly enough to prove it works. To give you an advantage, Veristat has assembled an extraordinary team of scientific-minded biostatisticians, programmers, data managers and data standards experts, supported by InStat™, Veristat’s purpose-built biometrics technology platform, to bring greater speed, consistency, and efficiency to statistical analysis and reporting.

Make Every Phase Build Toward What Comes Next
Biometrics work doesn't just produce results, it reveals what your data is actually telling you early enough to act on it, not after a trial's already locked in a direction. That's what our biometrics team is built for.
InStat™ adds a powerful technology layer to that expertise. Built by biometrics experts for clinical development, InStat™ structures study data to regulatory standards and automates statistical analysis and reporting through validated statistical engines, while keeping experienced biostatisticians at the center of the work.
View demo →
We bring biostatisticians, programmers, data managers, and data standards experts together under one roof: not siloed teams handing off work, but a group that thinks about your program as a whole. Bring that integrated team together with InStat™ and deep expertise in adaptive trial designs, and you have a biometrics partner built to move efficiently from data to analysis to decision.
The result: data you can trust, insight you can act on, and a clearer path to your next decision.
HOW IT WORKS
Your data moves through several critical stages between first patient enrolled and final submission.
Our biometrics team supports you at every step:
Build and manage your data.
We design, build, and deploy your clinical trial database, capturing clean, reliable data from day one.
Program your datasets.
Our statistical programmers transform raw trial data into accurate, analysis-ready datasets. InStat™ brings automation and standardization into the process, helping accelerate the path from study data to analysis-ready outputs.
Analyze and interpret.
Our biostatisticians combine scientific expertise with InStat™ technology to accelerate statistical analysis and reporting, helping you understand what your data means for your program’s next decision.
Standardize for submission.
We prepare your data into SDTM and ADaM formats, submission-ready for regulatory agencies around the world, with InStat™ supporting a structured, traceable path toward submission-ready deliverables.
Monitor for safety, throughout.
Independent Data Monitoring Committees provide ongoing oversight, protecting patient safety and reducing risk across the life of your trial.
Scale with the right team.
Through our FSP and resourcing model, we flex to meet your program's milestones, whenever and wherever you need us.
Proof Points
Lorem ipsum headline
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Therapeutic nuance, not templates
Fluent in plain language
Built for complexity
Scalable by design
Expertise amplified by technology
InStat™ combines automation with expert biostatistician oversight to accelerate analysis without sacrificing scientific rigor.
Veristat's Offerings
Every one of these services is backed by hands-on experience in the areas that matter most: adaptive designs, rare disease and small populations, complex biologics data, and independent safety oversight, delivered at the speed your program needs.
Data Management
Accelerating the design, build, and deployment of clinical trial databases faster than the industry norm.
Learn more →Biostatistics
Expert statistical planning and analysis, strengthened by InStat™ technology, to move efficiently from study data to reliable results and development decisions.
Learn more →Statistical Programming
Speed, quality, and expert programming to perform accurate clinical trial data sets for analysis.
Learn more →InStat™ by Veristat
Purpose-built biometrics technology that combines specification-driven automation, validated statistical engines, and expert oversight to accelerate statistical analysis and reporting.
Learn more →Data Standardization
Preparing clinical trial data into submission-ready format for regulatory agencies/authorities around the world.
Learn more →Data Monitoring Committees
Improve patient safety and reduce risks with proven and acceptable independent DMC models and administration best practices.
Learn more →FSP/Resourcing
Finding the right resources to meet your development program’s milestones and accelerate time to market is critical today.
Learn more →PROOF POINTS
Lorem ipsum headline
Regulatory Writing Services
Move from data and documentation to a fully coordinated submission.
Agency Meetings:
Prepare to present your data and development plan directly to regulators.
Adaptive Designs:
Build flexibility into your trial design using simulation and biostatistics expertise.
Marketing Applications:
Take your submission-ready data through to approval.
OUR EXPERTS
Experienced People at the Table
Complex programs benefit from experienced people who can see beyond their individual workstream. Veristat brings senior clinical, statistical, regulatory, medical, and operational experts together around your program, providing the scientific depth and cross-functional perspective needed to navigate difficult decisions.
Amil Evara
Partner
61, Alexandria USA
Nat Reynolds
Partner
61108 Block Locks, North Otto
Suzan Lois
Graphic Designer
73421 O'Conner Divide, Cortezmouth
James Oliver
Associate Partner
Apt. 843 32344 Schumm Union, Domenicland
PROOF & RESOURCES
Perspectives on Complex Clinical Development
Explore perspectives from Veristat experts on clinical trial design and execution, regulatory strategy, biometrics, rare disease, oncology, cell and gene therapy, and other challenges shaping Phase I–IV development.